ScottArthurKonoDO

Physician

Overview of Dr. Kono

Dr. Scott Kono is an oncologist in Denver, CO and is affiliated with University of Colorado Hospital. He received his medical degree from Chicago College of Osteopathic Medicine at Midwestern University and has been in practice 14 years. Dr. Kono accepts several types of health insurance, listed below. He is one of 124 doctors at University of Colorado Hospital who specialize in Oncology. He has more than 20 publications and over 500 citings.

Office
100 Cook Street Suite 202
Denver, CO 80206
Book by Phone+1(720) 782-5698

Fax+1 720-516-9441
Is this information wrong?

Education & Training

University of ColoradoFellowship, Hematology and Medical Oncology, 2007 - 2010
University of Kansas School of MedicineResidency, Internal Medicine, 2003 - 2006
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2003

Certifications & Licensure

CO State License 2008 - 2025
GA State License 2010 - 2013
American Board of Internal Medicine Medical Oncology

Clinical Trials

Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck Start of enrollment: 2010 Mar 01
Completed
Phase 1

Publications & Presentations

PubMed

9 citations
Phase II Study of Taselisib in-Mutated Solid Tumors Other Than Breast and Squamous Lung Cancer: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol I.
Ian E Krop, Opeyemi A Jegede, Juneko E Grilley-Olson, Josh D Lauring, Edith P Mitchell, James A Zwiebel, Robert J Gray, Victoria Wang, Lisa M McShane, Larry V Rubinste...> ;JCO Precision Oncology. 2022 Feb 1
5 citations
Switching from Biologic to Biosimilar Products: Insight from an Integrated Health Care System.
Bharati Bhardwaja, Shilpa Klocke, Ekim Ekinci, Adam Jackson, Scott Kono, Kari L. Olson> ;Biodrugs. 2021 Nov 24
15 citations
Socioeconomic Factors Affect Outcomes in Well-Differentiated Thyroid Cancer:
Warren C. Swegal, Michael C. Singer, Edward L. Peterson, Heather Spencer Feigelson, Scott A. Kono, Susan Snyder, Thuy Anh N. Melvin, Gabriel Calzada, Nirupa R. Ghai, D...> ;Otolaryngology--Head and Neck Surgery. 2016 Mar 1
1 citations
Pilot Study of a Novel Population of Head and Neck Cancer Patients in the CRN
Steven S. Chang, Kevin H Wang, Scott A. Kono, Daniel M. Saman, Susan Snyder, Thuy-Anh Melvin, Gabriel Calzada> ;Otolaryngology--Head and Neck Surgery. 2015 Jan 1
39 citations
Phase 1 and pharmacokinetic study of everolimus in combination with cetuximab and carboplatin for recurrent/metastatic squamous cell carcinoma of the head and neck
Nabil F. Saba, Selwyn J. Hurwitz, Kelly R. Magliocca, Sungjin Kim, Taofeek K. Owonikoko, R. Donald Harvey, Suresh S. Ramalingam, Zhengjia Chen, Jackie Rogerio, Jennife...> ;Cancer. 2014 Dec 15
11 citations
Patients' perceptions of complementary and alternative medicine in head and neck cancer: a qualitative, pilot study with clinical implications.
Kristopher A Hendershot, Margie D. Dixon, Scott A. Kono, Dong M. Shin, Rebecca D. Pentz> ;Complementary Therapies in Clinical Practice. 2014 Nov 1
54 citations
Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.
Nabil F. Saba, Selwyn J. Hurwitz, Scott A. Kono, Chung S. Yang, Yang Zhao, Zhengjia Chen, Gabe Sica, Susan Muller, Rachel Moreno-Williams, Melinda M. Lewis, William Gr...> ;Cancer Prevention Research. 2014 Mar 1
138 citations
Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009
Benjamin E. Ansa, Michael Goodman, Kevin C. Ward, Scott A. Kono, Taofeek K. Owonikoko, Kristin Higgins, Jonathan J. Beitler, William Grist, Trad Wadsworth, Mark W. El-...> ;Cancer. 2013 Jul 15
35 citations
Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non–Small-Cell Lung Cancer
Suresh S. Ramalingam, Taofeek K. Owonikoko, Madhusmita Behera, Janakiraman Subramanian, Nabil F. Saba, Scott A. Kono, Anthony A. Gal, Gabriel Sica, R. Donald Harvey, Z...> ;Journal of Thoracic Oncology. 2013 Mar 1
47 citations
Chemoprevention of Head and Neck Cancer by Simultaneous Blocking of Epidermal Growth Factor Receptor and Cyclooxygenase-2 Signaling Pathways: Preclinical and Clinical ...
Dong M. Shin, Hongzheng Zhang, Nabil F. Saba, Amy Y. Chen, Sreenivas Nannapaneni, A.R.M. Ruhul Amin, Susan Muller, Melinda M. Lewis, Gabriel Sica, Scott A. Kono, Johan...> ;Clinical Cancer Research. 2013 Mar 1
218 citations
Adenoid cystic carcinoma of the head and neck: Incidence and survival trends based on 1973-2007 Surveillance, Epidemiology, and End Results data.
Christopher L. Ellington, Michael Goodman, Scott A. Kono, William Grist, Trad Wadsworth, Amy Y. Chen, Taofeek K. Owonikoko, Suresh S. Ramalingam, Dong M. Shin, Fadlo R...> ;Cancer. 2012 Sep 15
8 citations
EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab
Scott A. Kono, Missak Haigentz, Sue S. Yom, Nabil F. Saba> ;Chemotherapy Research and Practice. 2012 Sep 27
35 citations
Single agent maintenance therapy for advanced stage non-small cell lung cancer: A meta-analysis
Madhusmita Behera, Taofeek K. Owonikoko, Zhuo Georgia Chen, Scott A. Kono, Fadlo R. Khuri, Chandra P. Belani, Suresh S. Ramalingam> ;Lung Cancer. 2012 Aug 1
27 citations
Antiepidermal growth factor receptor therapy in squamous cell carcinoma of the head and neck.
Walid L. Shaib, Scott A. Kono, Nabil F. Saba> ;Journal of Oncology. 2012 Jun 19
56 citations
HPV Positive Squamous Cell Carcinoma of the Oropharynx. Are we Observing an Unusual Pattern of Metastases
Susan Muller, Fadlo R. Khuri, Scott A. Kono, Jonathan J. Beitler, Dong M. Shin, Nabil F. Saba> ;Head and Neck Pathology. 2012 Apr 15
42 citations
Adding to the Mix: Fibroblast Growth Factor and Platelet-derived Growth Factor Receptor Pathways as Targets in Non–small Cell Lung Cancer
Scott A. Kono, Lynn E. Heasley, Robert C. Doebele, D.R. Camidge> ;Current Cancer Drug Targets. 2012 Jan 31
81 citations
Fibroblast Growth Factor Receptors Are Components of Autocrine Signaling Networks in Head and Neck Squamous Cell Carcinoma Cells
Marianne E. Marshall, Trista K. Hinz, Scott A. Kono, Katherine R. Singleton, Brady Bichon, Kathryn E. Ware, Lindsay Marek, Barbara Frederick, David Raben, Lynn E. Heasley> ;Clinical Cancer Research. 2011 Aug 1
191 citations
Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed
D. Ross Camidge, Scott A. Kono, Xian Lu, Sonia Okuyama, Anna E. Barón, Ana B. Oton, Angela M. Davies, Marileila Varella-Garcia, Wilbur A. Franklin, Robert C. Doebele> ;Journal of Thoracic Oncology. 2011 Apr 1
280 citations
Optimizing the Detection of Lung Cancer Patients Harboring Anaplastic Lymphoma Kinase (ALK) Gene Rearrangements Potentially Suitable for ALK Inhibitor Treatment
D. Ross Camidge, Scott A. Kono, A. Flacco, Aik Choon Tan, Robert C. Doebele, Qing Zhou, Lucio Crinò, Wilbur A. Franklin, Marileila Varella-Garcia> ;Clinical Cancer Research. 2010 Nov 15
52 citations
The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer.
Scott A. Kono, Marianne E. Marshall, Kathryn E. Ware, Lynn E. Heasley> ;Drug Resistance Updates. 2009 Aug 1
Surprised by stage III: unexpected N2 lymph node involvement found during surgery for early-stage NSCLC.
Scott A. Kono, Michael J. Weyant, Wilbur A. Franklin, Laurie E. Gaspar, D. Ross Camidge> ;Oncology. 2009 Apr 30
29 citations
Contemporary empyema necessitatis.
Scott A. Kono, Trenton D. Nauser> ;The American Journal of Medicine. 2007 Apr 1
Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
Kawai T, Suzuki M, Kono S, Shinomiya N, Rokutanda M, Takagi K, Ogata T, Tamai S> ;Cancer. 1994-11-01
Sweet syndrome in patients with solid tumors.
Cohen PR, Holder WR, Tucker SB, Kono S, Kurzrock R> ;Cancer. 1993-11-01
Join now to see all

Hospital Affiliations

University of Colorado HospitalAurora, Colorado

Insurance Accepted

BCBS Blue Card PPO
BCBS Georgia Blue Choice HMO
BCBS Georgia BlueChoice Option POS
BCBS Illinois PPO
BCBS Kansas City Preferred-Care Blue PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
MagnaCare PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment